Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined (Menomune)
Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined is an FDA-licensed reference biologic from Sanofi Pasteur Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1999
Reference approved
Reference product
Menomune Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined
Sanofi Pasteur Inc.
- Approved
- Dec 09, 1999
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined, in chronological order.
Reference approval
Approval date of the reference Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined product.
26 yr 10 mo ago
Frequently asked questions
Are there biosimilars approved for Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined (Menomune)?
No 351(k) biosimilars or interchangeable biosimilars referencing Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.